Long-acting cardioplegia solution results in better outcomes for pediatric heart surgery patients
Monday, May 16, 2016 - 08:20
in Health & Medicine
During heart surgery, it is sometimes necessary to temporarily stop cardiac activity, a process known as cardioplegia. Specific myocardial protection techniques are necessary for pediatric use. Cardiac surgeons have presented the results of a prospective, randomized trial of pediatric heart surgery patients that shows that the del Nido cardioplegia solution, a new, long-acting agent, offers significant advantages over conventional cardioplegia, including reduced cardiopulmonary bypass and aortic cross-clamp times and faster onset of action.